As per our research analysis report, the size of the global bioinformatics market is forecasted to worth USD 11.1 billion in 2020 and estimated to be growing at a CAGR of 19.29%, to reach USD 26.9 billion by 2025.
Bioinformatics is a combination of computer sciences, molecular biology, biotechnology, and statistics. It is a field of the collection, classification, storage and analysis of biological and biochemical information by using computer-based software tools. Genomics and proteomics are activities in that bioinformatics used on a large scale. Recently, the field includes artificial intelligence and computer sciences for the development in microbiology and genetic codes section. Additionally, several companies are expanding their innovation in gene expression, gene sequencing, and new drug discovery studies.
MARKET DRIVERS
Growing support and initiatives from the various governments and implementation of new technologies are majorly propelling the growth of the global bioinformatics market.
The global bioinformatics market is expected to have significant growth by rising government initiatives and funding genomics-based R & D, increasing use of technology in drug discovery and biomarker development. Besides, the gradual reduction of DNA sequencing costs is also an essential driver of the industry's expected progress is the primary drivers in the global bioinformatics market.
The rise in demand for integrated data and the cost of sequencing decreases is creating growth opportunities for the market. Besides, the need for nucleic acid and protein sequencing will continue to increase, and increasing proteomics & genomics applications are impacting the growth of the market towards positive. The global bioinformatics market is expected to grow significantly shortly. Government and private sector investments on the development of innovative products are expected to drive market growth during the forecast period.
The data storage and analysis application that can store large amounts of genomic and proteomic information and facilitate research activities from aging & carcinogenesis to the prevention and treatment of genetic diseases are anticipated to present growth opportunities for the market. Significant contributions to the development of the industry during the forecast period are also expected in the global bioinformatics market.
MARKET RESTRAINTS
The lack of skilled staff, standard data formats, lack of easy-to-use tools available at bargain prices and inabilities to use the platform to integrate large datasets generated by bioinformatics are expected to hinder the growth of the bioinformatics market growth.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Covered |
By Sector, Products & Services, Application and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
This research report on the Global Bioinformatics Market has been segmented and sub-segmented based on the sector, products & services, application and region.
Bioinformatics Market - By Sector
Based on sector, medical biotechnology segment accounted for the largest share in this segment owing to the growing need for developing new drugs at low prices and the use of bioinformatics in pharmaceutical companies for the development of drugs. The bioinformatics has two most traditional applications in target drug discovery and validation process. Also, the academic sector is anticipated to grow at a healthy rate in the market during the forecast period due to developing institutes research and projects.
Bioinformatics Market - By Products and Services
Based on products & services, Knowledge management tools has the largest share in this segment and bioinformatics platforms is the fastest-growing sub-segment.
The data analytics is estimated to showcase a robust CAGR from 2019 to 2024 due to demand for data solutions for high performing sequencing. Genetic sequencing is expected to have the fastest growth in the coming years due to rising awareness about genome and exome technologies because of low cost.
Bioinformatics Market - By Application
Based on the applications segment, Genomics accounts for the largest market share in the applications segment. Genomics application segment is grabbing growth in this market due to increasing the Application in gene sequencing. Proteomics segment is expected to grow in the coming years due to new technologies and number of research projects in bioinformatics market.
Bioinformatics Market - By Region
Regionally, North America has the largest market share in the global bioinformatics market, followed by Europe. Asia-Pacific is the fastest-growing market in the world. Factors like rising funding for research, growing demand for bioinformatics in proteomics and genomics research and technological advancements is expected to drive the rise of this market.
The Bioinformatics market in the Asia Pacific will grow at the fastest rate with double-digit expected growth from 2019 to 2024, thanks to the improved healthcare infrastructure and development plans adopted by regional pharmaceutical companies. It is expected to be accomplished. There are many infectious disease patients in the Asia-Pacific region which are accelerating the demand of the market.
APAC accounts for 60% of the world's total population, so a low prevalence means a high number of infected people. Emerging economies, such as India and Australia, also contribute to revenue sharing and progress elsewhere in the Asia-Pacific region. As service outsourcing gains momentum, an increasing number of Asian countries are participating in establishing infrastructure and are expected to influence sector revenue generation through government investment and academic innovation.
TOP COMPANIES IN THE MARKET
Major companies operating in the global bioinformatics market are Agilent Technologies, Affymetrix Inc., Applied Biological Materials (ABM), 3rd Millenium Inc., Illumina Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Biomax Informatics Ag, DNAnexus, Inc. and Waters Corporation.
There are several biotech companies, and research institutes have taken the initiative to conduct a study of gene sequencing for the growth of the bioinformatics market. Using rapid-friendly software such as RasMol, BALL that is used for detection of toxicity before the drug discovery processing in the market is factor increase the growth of the global market.
RECENT MARKET DEVELOPMENTS
In 2020, Roche purchased the Stratos genomics to innovation into Roche nanopore sequencing that combines the electronics and biological components for fast and low-cost diagnostic testing of DNA sequencing.
In 2019, the Qiagen joined with N-of-one for the development of clinical bioinformatics services for complex genomic data management. Also, it helps to expand their decision-support solutions with consideration of software, content and services. It provides clinical trials matching services and oncology database of patients to the organization.
In 2019, NEC acquired Oncommunity, an immune profiler which uses machine learning to data sequencing for the cancerous patients. The development will provide better cancer treatment in the bioinformatics market.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Sector
5.1.1 Animal Biotechnology
5.1.2 Environmental Biotechnology
5.1.2.1 Alternative Energy Sources
5.1.2.2 Waste Clean-Up/Bioremediation
5.1.2.3 Climate Change Studies
5.1.3 Agricultural Biotechnology
5.1.3.1 Crop Yield Improvement
5.1.3.2 Pest Resistance
5.1.3.3 Improvement of Plant Resistance
5.1.3.4 Biodiversity Informatics
5.1.3.5 Nutritional Quality Improvement
5.1.4 Forensic Biotechnology
5.1.5 Medical Biotechnology
5.1.5.1 Drug Development
5.1.5.2 Clinical Diagnostics
5.1.5.3 Molecular Medicine
5.1.5.3.1 Personalized Medicine
5.1.5.3.2 Preventive Medicine
5.1.5.4 Gene Therapy
5.1.5.5 Reproductive Biotechnology
5.1.6 Academics
5.1.7 Other sectors
5.1.8 Y-o-Y Growth Analysis, By Sector
5.1.9 Market Attractiveness Analysis, By Sector
5.1.10 Market Share Analysis, By Sector
5.2 Products and Services
5.2.1 Bioinformatics Platforms
5.2.1.1 Sequence Analysis Platforms
5.2.1.2 Sequence Alignment Platforms
5.2.1.3 Sequence Manipulation Platforms
5.2.1.4 Structural and Functional Analysis Platforms
5.2.1.5 Other Bioinformatics Platforms
5.2.2 Knowledge Management Tools
5.2.2.1 Generalized Knowledge Management Tools
5.2.2.2 Specialized Knowledge Management Tools
5.2.3 Bioinformatics Services
5.2.3.1 Data Analysis
5.2.3.2 Sequencing Services
5.2.3.3 Other Bioinformatics Services
5.2.3.4 Database and Management Services
5.2.4 Y-o-Y Growth Analysis, By Products and Services
5.2.5 Market Attractiveness Analysis, By Products and Services
5.2.6 Market Share Analysis, By Products and Services
5.3 Application
5.3.1 Proteomics
5.3.2 Transcriptomics
5.3.3 Molecular Phylogenetics
5.3.4 Chemoinformatics
5.3.5 Drug Design and Genomics
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Sector
6.1.3.2 By Products and Services
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Sector
6.1.4.2 By Products and Services
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Sector
6.1.5.2 By Products and Services
6.1.5.3 By Application
6.2 Middle-East
6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Agilent Technologies
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Affymetrix Inc.
8.3 Applied Biological Materials (ABM)
8.4 3rd Millenium Inc.
8.5 Illumina Inc.,
8.6 Thermo Fisher Scientific Inc.
8.7 Qiagen N.V.
8.8 Biomax Informatics Ag
8.9 DNAnexus, Inc.
8.10 Waters Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
